Terron et al., Chemical Abstracts, vol. 122, No. 204541. |
Terron et al., “Pharmacological Screening of Some Quinoline Derivatives in Canine Vascular Smooth Muscle”, Archives of Medical Research, (1994), 25: pp. 2375-2380. |
Zimmerman et al., “Synthesis and Structure of Molecular Tweezers Containing Active Site Functionality”, J. Am. Chem. Soc., (1991), 113: pp. 183-196. |
Glennon et al., “5-HT1 and 5-HT2 Binding Characteristics of Some Quipazine Analogues”, J. Med. Chem., (1986), 29: pp. 2375-2380. |
Schmidt et al., “The Effect of Diarylalkylpiperazines and Related Compounds on Plasma and Liver Lipids and Liver Size”, Toxicology and Applied Pharmacology, (1965) 7: pp. 257-267. |
Regnier et al., “Synthesis and Vasoilator Activity of New Piperazine Derivatives”, J. Med. Chem., vol. 11, No. 6, 1968, pp. 1151-1155. |
Hori, M. et al., “Novel 4-Phenoxy-2-(1-piperazinyl)quinazolines as Potent Anticonvulsive and Antihypoxic Agents”, Chem. Pharm. Bull., vol. 38, No. 3, 1990, pp. 681-687. |
Sekiya, T. et al.: “Pyrimidine Derivatives.VI. Synthesis of 2-(1-Piperazinyl)-5,6-polymethylenepyrimidine Derivatives and Determination of Their Hypoglycemic Activity”, Chem. Pharm. Bull., vol. 31, No. 7, 1983, pp. 2254-2261. |
Cervena, A. et al., “Napthylpiperazines and Tetralylpiperazines: Synthesis and Pharmacological Properties”, Coll. Czech. Chem. Commun., vol. 40, 1975, pp. 1612-1622. |
Boyfield, I. et al., “N-(substituted-henyl) piperazines: antagonists with high binding and functional selectivity for dopamine D4 receptors”, Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 11, Jun. 4, 1996, pp. 1227-1232. |
Hadley, M.S.: “D4 Receptors and Their Antagonists”, Medicinal Research Reviews, vol. 16, No. 6, 1996, pp. 507-526. |
Kulagowski, J.J. et al., “Dopamine D4 Receptor Antagonists”, Curr. Pharm. Des., vol. 3, No. 4, Apr. 1997, pp. 355-366. |
Seeman, P. et al., “Multiple Receptors for Dopamine (D2, D3, D4)” Advanced in the Biosciences, vol. 37, 1982, pp. 61-70. |
Lumma, W.C., et al., “Piperazinylquinoxalines with Central Serotonimimetic Activity”, J. Med. Chem., vol., 24, 1981, pp. 93-101. |
Joseph-Nathan, P. et al. “13C NMR Study of Quizapines”, Magn. Reson. Chem.,vol. 28, 1990, pp. 299-304. |
Nathis, C.A. et al., “Binding Potency of 6-Nitroquipazine Analogues for the 5-Hydroxytryptamine Reuptake Complex”, J. Pharm. Pharmacol;., vol. 46, 1994, pp. 751-754. |
Glennon et al., J. Med. Chem. 34, p. 3360-3365 (1991). |